Park Ha Biological Technology is trading at $2.21, up 15.16%, with biotech-sector support.

  • No clear company-specific announcement explaining the November 4 move was identified; available coverage characterized it as sector-related.
  • Biotech ETF XBI was up about 2.1% during the session. The broader market was also sharply higher, but the available evidence points more specifically to biotech-sector support.
  • No trading-volume figure for the live move was provided.